|
1
|
Calcium antagonists for aneurysmal subarachnoid haemorrhage.
|
Cochrane Database Syst Rev
|
2007
|
2.08
|
|
2
|
Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage.
|
Cochrane Database Syst Rev
|
2004
|
1.16
|
|
3
|
Calcium antagonists for aneurysmal subarachnoid haemorrhage.
|
Cochrane Database Syst Rev
|
2005
|
1.13
|
|
4
|
Auckland Stroke Outcomes Study. Part 2: Cognition and functional outcomes 5 years poststroke.
|
Neurology
|
2010
|
0.96
|
|
5
|
Risk factors for Alzheimer's disease in Russia: a case-control study.
|
Eur J Neurol
|
2006
|
0.91
|
|
6
|
The spectrum captured: a methodological approach to studying incidence and outcomes of traumatic brain injury on a population level.
|
Neuroepidemiology
|
2011
|
0.85
|
|
7
|
Calcium antagonists for aneurysmal subarachnoid haemorrhage.
|
Cochrane Database Syst Rev
|
2002
|
0.84
|
|
8
|
Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
|
Heart
|
2009
|
0.83
|
|
9
|
Enzogenol for cognitive functioning in traumatic brain injury: a pilot placebo-controlled RCT.
|
Eur J Neurol
|
2013
|
0.79
|
|
10
|
Prevalence, natural course and predictors of depression 1 year following traumatic brain injury from a population-based study in New Zealand.
|
Brain Inj
|
2015
|
0.75
|
|
11
|
[Comment on the article by A.L. Bratsun "Risk factors for the Alzheimer's type of dementia"].
|
Zh Nevrol Psikhiatr Im S S Korsakova
|
1999
|
0.75
|